Vision-Ease Lens (VEL), a manufacturer of ophthalmic lenses, learned yesterday that its manufacturing facility in Jakarta, Indonesia, sustained damage from a major fire. All employees evacuated safely and damage is currently being assessed. The Jakarta facility is one of two manufacturing facilities owned by VEL.
Bausch & Lomb today announced that the company's Lo-Torque lens design demonstrates significantly better rotational recovery, which can lead to more consistent vision, compared with Acuvue's accelerated stabilization design. These findings from two clinical studies were presented at Academy 2009, the American Academy of Optometry annual meeting in Orlando, Fla.
After helping thousands of patients get their lives back through minimally invasive endoscopic spinal surgery at their facilities in Tampa and Scottsdale, the Laser Spine Institute announces the opening of a new medical center in Philadelphia. In the last four years, more than 1,000 residents of Pennsylvania, Maryland, Delaware, New Jersey and New York have traveled to LSI to gain relief from their debilitating back and neck pain. LSI is now able to provide innovative spinal procedures to meet the overwhelming demand from residents of the Northeast with the new Pennsylvania facility. The surgery center offers two comfortable patient lounge areas, four examination rooms, an open and revitalizing pre-op and post-op space and two state-of-the-art operating rooms with the most technologically advanced equipment available. Situated in suburban Philadelphia between Valley Forge and King of Prussia, the location takes advantage of the beautiful seasons of eastern Pennsylvania.
Research into designing and building unique 'metamaterials' has received a £4.9 million funding boost from The Leverhulme Trust, it is announced today. Metamaterials can be used for invisibility 'cloaking' devices, sensitive security sensors that can detect tiny quantities of dangerous substances, and flat lenses that can be used to image tiny objects much smaller than the wavelength of light.
Ocutec Ltd, the medical devices specialist today announced at the American Academy of Optometry Meeting in Orlando CE Mark approval for its first poly(ethylene )glycol (PEG) hydrogel-based contact lens product. In initial patient acceptance trials, this next generation of lenses has demonstrated superior oxygen permeability compared to existing hydrogel based lenses. It is anticipated that the lenses will provide similar health benefits to silicone hydrogels without the drawbacks of incorporating hydrophobic silicone into the lens polymer.
Oakley, Inc. today announced the introduction of an ultra-premium product collection called Elite. The groundbreaking innovations in the new collection represent the pinnacle of product design, bringing the ultimate in technology and aesthetics to discerning consumers who demand the very best.
As many as 10 million people around the world suffer from cataracts. Thomas Kohnen of the Goethe University in Frankfurt and his coauthors discuss cataract surgery with the implantation of an artificial lens in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2009; 106[43]: 695�).
GlassesShop.com (GS) is planning to commission professional research companies to launch a survey every two years, targeting one million glasses wearers in North America. In this year's survey, approximately 150,000 copies were received. Compared to the figures last year, the ratio shows that people who believe the sales of glasses can be e-commercialized and those with experience of eyeglasses shopping online have greatly increased.
Skiers, snowboarders and other outdoor sports enthusiasts in North America have a new solution to one of the biggest problems they encounter -- fogging of goggles and face shields. Bausch & Lomb's new FogShield Sport(TM) pre-moistened towelettes simultaneously prevent fog from forming on goggles for eight hours or more and help keep lenses clean with just one application.
A recently devised method of imaging the chemical communication and warfare between microorganisms could lead to new antibiotics, antifungal, antiviral and anti-cancer drugs, said a Texas AgriLife Research scientist.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.